85
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
281079
Telios Pharma develops therapies for inflammatory diseases, focusing on BTK inhibitors targeting mast cells.
Iain Dukes: Founder- Erkki Ruoslahti: Founder
About the Company
Telios Pharma is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory diseases. The company is working on first-in-class topical and oral BTK inhibitor programs that target mast cells. These programs aim to provide new treatment options for patients suffering from inflammatory conditions.
